is cagrilintide a glp-1 new drug combo of semaglutide (GLP-1 receptor agonist) with (amylin analogue) failed to do as well as tirzepatide (GLP-1/GIP receptor agonist). The future of these medicines hitting different receptors Cagrilintide vs Semaglutide: Which GLP-1
Description
83), which eventually led to FDA approval of interferon-beta 1b
J., & Whitworth, J
AOD-9604 is not a substitute for GLP-1 agonists in clinical obesity
doi: 10.1126/science.3086977
However, subsequent analysis showed that 500mcg produced nearly identical results to 1mg in body composition changes
Safety cannot be established outside of controlled laboratory research
